Tawam and Al Ain Hospital
Al Ain City, United Arab Emirates
NCT Number: NCT06605677
This study is designed to use a questionnaire to assess doctors' knowledge, attitudes, and practices regarding bloodstream bacterial infections and antibiotic use in Tawam and Al Ain tertiary Hospitals (both hospitals have the same medical team) in Al Ain City, UAE.
Interested in participating?
Request InfoAll sexes
Observational
Al Ain City, United Arab Emirates
Background: Bloodstream bacterial infection is a serious medical problem and one of the leading causes of death worldwide among all age groups. Appropriate and early antibiotic use has been associated with better outcomes based on many clinical trials. On the other hand, misuse and abuse of antibiotics have been linked to long hospital stays, significant morbidity and mortality, increased medical costs and rising antimicrobial resistance (AMR). Statistics in hospitals involved in the study, showed increased antibiotic consumption compared to previous years and other regional healthcare facilities. Rates of AMR in the UAE have increased significantly in the last decade, based on the 2022 annual report.
Aims and objectives This study will assess knowledge, attitude and practice regarding bloodstream bacterial infections and antibiotics use among doctors. It is a questionnaire-based cross-sectional descriptive study that will be conducted at Tawam and Al Ain Hospitals (tertiary hospital, both hospitals have the same medical team).
The investigators want to explore the degree of knowledge and attitude, assess the appropriate usage of antibiotics among doctors in different subspecialties, assess any possible barriers, and find solutions such as medical education for this challenging medical problem.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All physicians with valid medical licenses working in Tawam and Al Ain tertiary hospitals
Exclusion criteria
Infectious diseases physicians and Microbiologists
An online questionnaire will be sent through e-mail to participants. It is divided into 4 sections: demography and general information 9 questions, knowledge 10 questions, attitude 10 questions and practice 10 questions. No previous similar studies were conducted in the United Arab Emirates (UAE) or internationally based on a search in PubMed and Cochrane library. Hence a validated questionnaire is lacking. Therefore, the questionnaire for this study is designed based on questions encountered daily by colleagues during the consultation, and it can serve the purpose of this study. Consent will be obtained and signed electronically by participants before starting the questionnaire. Participation involves minimal risk. Responses will be anonymous and confidential. Participants' involvement is voluntary, and they can withdraw at any time without any consequences. The time to complete the questionnaire is around 10-15 minutes. Each response will be saved using a unique identifier number.
Time frame: 1 year
Questions to assess physicians' knowledge related to basic microbiology, bacterial infections and antibiotic spectrum of activity using dichotomous questions; yes/no.
Time frame: 1 year
Questions to assess physicians' attitude in bacteremia management using dichotomous questions; yes/no, Likert scale or multiple choices.
Time frame: 1 year
Questions to assess physicians' practice in bacteremia management using dichotomous questions; yes/no, or multiple choices.
Abu Dhabi Health Services Company
Other Gov
Knowledge Attitude and Practice Regarding Bloodstream Bacterial Infections and Antibiotics Usage Among Doctors in a Tertiary Hospital in Al Ain City, UAE: A Cross-Sectional Descriptive Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06874920
Bacteremia, Bacterial Infections
Milan, Italy
View Trial DetailsNCT05721781
Bacteremia, Bacterial Infections
Boston, Massachusetts, United States
View Trial DetailsNCT06821282
Bacteremia, Bacterial Infections
Kinshasa, Kinshasa City, Democratic Republic of the Congo
View Trial DetailsNCT05296590
Bacteremia, Bacteremia Sepsis
Detroit, Michigan, United States
View Trial Details